Company page

Drugs Made In America Acquisition Ii Corp.

Drugs Made In America Acquisition II Corp. (ticker: DMII) is a public company operating in the American market, with a market capitalization of approximately $643.37 million. The company focuses on the pharmaceutical sector, aiming to contribute to the production and availability of drugs made in the United States. DMII is positioned to play a role in the growing demand for domestic drug manufacturing.

profileDMII:NASDAQAI content: aiUpdated June 24, 2026/company/drugs-made-in-america-acquisition-ii-corp/c-mlifv5nd
Drugs Made In America Acquisition Ii Corp. logo
Ticker
DMII:NASDAQ
Asset type
Stock
Market cap
$643.4M
Sector
Finance
Industry
Financial Conglomerates
Exchange
NASDAQ
Currency
USD